Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Periodic salbutamol in facioscapulohumeral muscular dystrophy: a randomized controlled trial.

Payan CA, Hogrel JY, Hammouda EH, Lacomblez L, Ollivier G, Doppler V, Eymard B, Attarian S, Pouget J, Desnuelle C, Laforêt P.

Arch Phys Med Rehabil. 2009 Jul;90(7):1094-101. doi: 10.1016/j.apmr.2008.12.027.

PMID:
19577021
2.

[Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene].

Pou Serradell A, Lloreta Trull J, Corominas Torres JM, Hammouda EH, Urtizberea JA, Richard P, Brais B.

Neurologia. 2004 Jun;19(5):239-47. Spanish.

PMID:
15150706
3.

High incidence of sudden death with conduction system and myocardial disease due to lamins A and C gene mutation.

Bécane HM, Bonne G, Varnous S, Muchir A, Ortega V, Hammouda EH, Urtizberea JA, Lavergne T, Fardeau M, Eymard B, Weber S, Schwartz K, Duboc D.

Pacing Clin Electrophysiol. 2000 Nov;23(11 Pt 1):1661-6.

PMID:
11138304
4.

Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy.

Bonne G, Di Barletta MR, Varnous S, Bécane HM, Hammouda EH, Merlini L, Muntoni F, Greenberg CR, Gary F, Urtizberea JA, Duboc D, Fardeau M, Toniolo D, Schwartz K.

Nat Genet. 1999 Mar;21(3):285-8.

PMID:
10080180

Supplemental Content

Loading ...
Support Center